Who we are

Launched in March 2020, COVID-NMA is an international initiative led by the Centre of Research in Epidemiology and StatisticS (METHODS Team) and Cochrane France with key partners the World Health Organization (WHO), Université Paris Cité, Inserm, CNRS, Centre for Evidence-Based Medicine Odense (CEBMO), University of Southern Denmark, Odense University Hospital, Epistemonkos Foundation, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, and University of Milan.

This initiative involves a broad multidisciplinary consortium.

Our Vision

Decisions on COVID-19 treatments and preventive interventions are informed through a living Evidence Ecosystem developed by an international collaborative effort.

Our missions

Our goals

Our project relies on three main pillars:

  1. Performing a living mapping of all registered trial evidence to help funders and researchers planning future trials, 
  2. Producing a living systematic review of trial evidence to support healthcare decision making 
  3. Assessing trials methodology and transparency to improve future research.

Our values and principles